The Board of Directors of Square Pharmaceuticals PLC. has recommended 105% Cash Dividend for the year ended June 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
212.2 BDT | -0.38% | +0.62% | +0.90% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.90% | 1.71B | |
+30.63% | 695B | |
+26.51% | 568B | |
-4.63% | 361B | |
+19.57% | 330B | |
+3.79% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.90% | 168B |
- Stock Market
- Equities
- SQURPHARMA Stock
- News Square Pharmaceuticals PLC.
- Square Pharmaceuticals PLC. Recommends Cash Dividend for the Year Ended June 30, 2023